Clinical Trials: Page 143
-
Bristol-Myers Squibb gains 'breakthough therapy' designation for cancer drug
The pharmaceutical company gains the designation from the FDA for an oncology product being developed for the treatment of multiple myeloma.
By Nicole Gray • May 21, 2014 -
FDA: Fluzone not linked with febrile seizures
After a CDC warning that Fluzone may be linked to the increase in febrile seizures during the winter of 2010-11, researchers looked at epidemiologic data. Their analysis confirmed no significant association.
By Nicole Gray • May 16, 2014 -
Explore the Trendline➔
National Institutes of Allergy and Infectious Diseases. (2016). "Human natural killer cell" [Micrograph]. Retrieved from Flickr.
TrendlineCell therapy
The continued emergence of CAR-T therapy has fueled research into next-generation approaches and new applications, such as its use in autoimmune diseases.
By BioPharma Dive staff -
Cetirix Orthopaedics obtains new financing, patents
Ceterix Orthopaedics, which makes surgical equipment for arthroscopic procedures, received two new patents and a new round of financing.
By Nicole Gray • May 16, 2014
Previous
To find more content, use the "Topics" in the menu above.
